Cargando…

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition

Background: in patients with chronic kidney disease (CKD), the inflammatory and pro-oxidant milieu may contribute to malnutrition development. In this study, we investigated the relationship between inflammation, advanced glycation end-products (AGEs), and their receptors (RAGEs) with malnutrition i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caldiroli, Lara, Molinari, Paolo, Dozio, Elena, Rigolini, Roberta, Giubbilini, Paola, Romanelli, Massimiliano M. Corsi, Castellano, Giuseppe, Vettoretti, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312066/ https://www.ncbi.nlm.nih.gov/pubmed/35883745 http://dx.doi.org/10.3390/antiox11071253

Ejemplares similares

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2021)

Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health
por: Dozio, Elena, et al.
Publicado: (2020)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease
por: Liu, Wenjun, et al.
Publicado: (2022)

Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2022)

Retracted: Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study
por: Molinari, Paolo, et al.
Publicado: (2023)

Predictive value of ELWI combined with sRAGE/esRAGE levels in the prognosis of critically ill patients with acute respiratory distress syndrome
por: Zhang, Chengliang, et al.
Publicado: (2023)

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020)

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
por: Dozio, Elena, et al.
Publicado: (2023)

esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation
por: Swanner, Jessica, et al.
Publicado: (2023)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease
por: Fuller, Kelly N. Z., et al.
Publicado: (2018)

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro
por: Miller, Suzanne, et al.
Publicado: (2016)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study
por: Du, Run, et al.
Publicado: (2018)

Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
por: Dozio, Elena, et al.
Publicado: (2017)

Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study
por: Galliera, Emanuela, et al.
Publicado: (2017)

SUN-LB131 Association of Receptor for Advanced Glycation End Product (RAGE) Gene Polymorphisms & Serum Levels of Soluble RAGE (sRAGE) With Metabolic Syndrome (MS) in Mexican Population
por: Gonzalez-Guerrero, Diana Elizabeth, et al.
Publicado: (2020)

sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Biswas, Subrata K.
Publicado: (2019)

Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM
por: Miranda, Edwin R., et al.
Publicado: (2019)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
por: Dozio, Elena, et al.
Publicado: (2020)

sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells
por: Zhang, Fang, et al.
Publicado: (2017)

Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients
por: Jung, Eul Sik, et al.
Publicado: (2017)

sRAGE in septic shock: a potential biomarker of mortality
por: Hamasaki, Mike Yoshio, et al.
Publicado: (2014)

DNA and sRAGE circulation in the early phase after polytrauma
por: Joly, P, et al.
Publicado: (2015)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2019)

Letter to the Editor, Reacting to: “APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism”
por: Mooldijk, Sanne S, et al.
Publicado: (2020)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss
por: Popp, Collin J, et al.
Publicado: (2022)

Effect of RAGE gene polymorphisms and circulating sRAGE levels on susceptibility to gastric cancer: a case–control study
por: Li, Taijie, et al.
Publicado: (2017)

Reply to Biswas: Acute and Chronic Effects of Cigarette Smoking on sRAGE
por: Pouwels, Simon D., et al.
Publicado: (2019)

The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients
por: Chiang, Kuang-Hsing, et al.
Publicado: (2018)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
por: Kim, Taehee, et al.
Publicado: (2023)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
por: Deo, Permal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_apncl84941jgj8ncgvo242qh52